Annals of the Rheumatic Diseases: 79 (9)

Editorial

To immunosuppress: whom, when and how? That is the question with COVID-19 (4 August, 2020) Free
Kevin L Winthrop, Xavier Mariette

Review

Paradoxical gastrointestinal effects of interleukin-17 blockers (21 July, 2020) Free
Marine Fauny, David Moulin, Ferdinando D'Amico, Patrick Netter, Nadine Petitpain, Djesia Arnone, Jean-Yves Jouzeau, Damien Loeuille, Laurent Peyrin-Biroulet

Viewpoint

Digital crowdsourcing: unleashing its power in rheumatology (11 June, 2020)
Martin Krusche, Gerd R Burmester, Johannes Knitza

Heroes and pillars of rheumatology

Erik Waaler (1903–1997): one of the founders of rheumatological immunology who discovered rheumatoid factor (5 June, 2020)
Roland Jonsson

Epidemiology

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study (20 July, 2020)
Sofia Ramiro, Rémy L M Mostard, César Magro-Checa, Christel M P van Dongen, Tom Dormans, Jacqueline Buijs, Michiel Gronenschild, Martijn D de Kruif, Eric H J van Haren, Tom van Kraaij, Mathie P G Leers, Ralph Peeters, Dennis R Wong, Robert B M Landewé
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences (21 July, 2020)
Piero Ruscitti, Federico Bruno, Onorina Berardicurti, Chiara Acanfora, Viktoriya Pavlych, Pierpaolo Palumbo, Alessandro Conforti, Francesco Carubbi, Ilenia Di Cola, Paola Di Benedetto, Paola Cipriani, Davide Grassi, Carlo Masciocchi, Annamaria Iagnocco, Antonio Barile, Roberto Giacomelli
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’ (26 May, 2020)
Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Hsu, Xiaoqing Fu, Ellen M Gravallese, Hyon K Choi, Jeffrey A Sparks, Zachary S Wallace
Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study (16 June, 2020)
Yao Huang, Zhe Chen, Yu Wang, Liang Han, Kai Qin, Wenya Huang, Ying Huang, Hui Wang, Pan Shen, Xin Ba, Weiji Lin, Hui Dong, Mingmin Zhang, Shenghao Tu
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases (12 June, 2020)
Jose L Pablos, Lydia Abasolo, Jose M Alvaro-Gracia, Francisco J Blanco, Ricardo Blanco, Isabel Castrejón, David Fernandez-Fernandez, Benjamín Fernandez-Gutierrez, María Galindo-Izquierdo, Miguel A Gonzalez-Gay, Sara Manrique-Arija, Natalia Mena Vázquez, Antonio Mera Varela, Miriam Retuerto, Alvaro Seijas-Lopez

Rheumatoid arthritis

Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial (1 June, 2020)
Elise van Mulligen, Angelique E Weel, J M Hazes, Annette van der Helm-van Mil, Pascal Hendrik Pieter de Jong
Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease (29 May, 2020)
Brian Bridal Løgstrup, Kevin Kris Warnakula Olesen, Dzenan Masic, Christine Gyldenkerne, Pernille Gro Thrane, Torkell Ellingsen, Hans Erik Bøtker, Michael Maeng
Applying cascaded convolutional neural network design further enhances automatic scoring of arthritis disease activity on ultrasound images from rheumatoid arthritis patients (5 June, 2020)
Anders Bossel Holst Christensen, Søren Andreas Just, Jakob Kristian Holm Andersen, Thiusius Rajeeth Savarimuthu
Bacterial citrullinated epitopes generated by Porphyromonas gingivalis infection—a missing link for ACPA production
(12 June, 2020)
Madeleine Jenning, Bianka Marklein, Jimmy Ytterberg, Roman A Zubarev, Vijay Joshua, Dirkjan van Schaardenburg, Lotte van de Stadt, Anca Irinel Catrina, Ute Nonhoff, Thomas Häupl, Zoltán Konthur, Gerd R Burmester, Karl Skriner

Spondyloarthritis

Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort (24 June, 2020)
Raphael Micheroli, Christoph Tellenbach, Almut Scherer, Kristina Bürki, Karin Niederman, Michael J Nissen, Pascal Zufferey, Pascale Exer, Burkhard Möller, Diego Kyburz, Adrian Ciurea

Systemic sclerosis

Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT (30 June, 2020)
Mariaelena Occhipinti, Cosimo Bruni, Gianna Camiciottoli, Maurizio Bartolucci, Silvia Bellando-Randone, Anna Bassetto, Giovanna Cuomo, Dilia Giuggioli, Giulia Ciardi, Alessio Fabbrizzi, Sara Tomassetti, Federico Lavorini, Massimo Pistolesi, Stefano Colagrande, Marco Matucci-Cerinic
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients (19 June, 2020)
Lorenzo Beretta, Guillermo Barturen, Barbara Vigone, Chiara Bellocchi, Nicolas Hunzelmann, Ellen De Langhe, Ricard Cervera, Maria Gerosa, László Kovács, Rafaela Ortega Castro, Isabel Almeida, Divi Cornec, Carlo Chizzolini, Jacques-Olivier Pers, Zuzanna Makowska, Ralf Lesche, Martin Kerick, Marta Eugenia Alarcón-Riquelme, Javier Martin, PRECISESADS SSc substudy group
PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis (1 June, 2020)
Yun Zhang, Lichong Shen, Honglin Zhu, Katja Dreissigacker, Diana Distler, Xiang Zhou, Andrea Hermina Györfi, Christina Bergmann, Xianyi Meng, Clara Dees, Thuong Trinh-Minh, Ingo Ludolph, Raymund Horch, Andreas Ramming, Georg Schett, Jörg H W Distler

Myositis

Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis (16 June, 2020) Free
Iago Pinal-Fernandez, Maria Casal-Dominguez, Assia Derfoul, Katherine Pak, Frederick W Miller, Jose César Milisenda, Josep Maria Grau-Junyent, Albert Selva-O'Callaghan, Carme Carrion-Ribas, Julie J Paik, Jemima Albayda, Lisa Christopher-Stine, Thomas E Lloyd, Andrea M Corse, Andrew L Mammen

Vasculitis

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis (24 June, 2020)
Rona M Smith, Rachel Bronwen Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Reem Aljayyousi, Jacqueline Andrews, Annette Bruchfeld, Brian Camilleri, Simon Carette, Chee Kay Cheung, Vimal Derebail, Tim Doulton, Lindsy Forbess, Shouichi Fujimoto, Shunsuke Furuta, Ora Gewurz-Singer, Lorraine Harper, Toshiko Ito-Ihara, Nader Khalidi, Rainer Klocke, Curry Koening, Yoshinori Komagata, Carol Langford, Peter Lanyon, Raashid Ahmed Luqmani, Hirofumi Makino, Carole McAlear, Paul Monach, Larry W Moreland, Kim Mynard, Patrick Nachman, Christian Pagnoux, Fiona Pearce, Chen Au Peh, Charles Pusey, Dwarakanathan Ranganathan, Rennie L Rhee, Robert Spiera, Antoine G Sreih, Vladimir Tesar, Giles Walters, Michael H Weisman, Caroline Wroe, Peter Merkel, David Jayne

Letters

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept (30 April, 2020)
Pierre-Marie Duret, Eden Sebbag, Auriane Mallick, Simon Gravier, Lionel Spielmann, Laurent Messer
Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey (28 April, 2020)
Alessandro Tomelleri, Silvia Sartorelli, Corrado Campochiaro, Elena Marina Baldissera, Lorenzo Dagna
Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19 (28 April, 2020)
Haralampos M Moutsopoulos
Imaging neoangiogenesis in rheumatoid arthritis (INIRA): whole-body synovial uptake of a ^99mTc-labelled RGD peptide is highly correlated with power Doppler ultrasound
(23 April, 2020)
Laura Attipoe, Khaldoun Chaabo, Julekha Wajed, Fahim-Ul Hassan, Dharsene Shivapatham, Matthew Morrison, Jim Ballinger, Gary Cook, Andrew P Cope, Toby Garrood
Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation (24 April, 2020)
Yueting Li, Jianwei Huo, Yihan Cao, Meiyan Yu, Yanan Zhang, Zhaohui Li, Chen Li, Wen Zhang
Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone (12 May, 2020)
Kevin Chevalier, Rakiba Belkhir, Raphaele Seror, Xavier Mariette, Gaetane Nocturne
Steroid-resistant sarcoidosis treated with baricitinib (7 May, 2020)
Morton Scheinberg, Fernando Maluf, Jairo Wagner

Electronic pages

Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients (29 May, 2019) Free
Marco Fornaro, Fabio Cacciapaglia, Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone
Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al
(14 August, 2019) Free
Rabia Agca, Sjoerd C Heslinga, S Rollefstad, S Heslinga, Anna Södergren, AG Semb, George D Kitas, Naveed Sattar, Michael T Nurmohamed
Response to: ‘Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al’ by Agca et al
(11 October, 2019) Free
Marco Fornaro, Fabio Cacciapaglia, Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone
Alcohol is not the missing link between Porphyromonas gingivalis-related periodontitis and radiological progression in early rheumatoid arthritis
(14 June, 2019) Free
Julien Hillion, Alexandre Bellier, Xavier Romand, Bruno Fautrel, Xavier Mariette, Franck Sagéloli, Athan Baillet, Philippe Gaudin
Response to: ‘Alcohol is not the missing link between Porphyromonas gingivalis related periodontitis and radiologic progression in early Rheumatoid arthritis’ by Hillion et al
(14 June, 2019) Free
Hubert Marotte, Stéphane Paul
Response to: ‘Response to: ‘Alcohol is not the missing link between Porphyromonas gingivalis related periodontitis and radiologic progression in early Rheumatoid arthritis’ by Hillion et al’ by Marotte and Paul
(31 July, 2019) Free
Alexandre Bellier, Xavier Romand, Athan Baillet
Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis (31 May, 2019) Free
Toshihiro Sugiyama
Response to: ‘Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis’ by Sugiyama (31 May, 2019) Free
Gulsen Ozen, Kaleb Michaud
Can biomarkers differentiate psoriatic arthritis from osteoarthritis? (1 June, 2019) Free
Jian Tian, Chao Cheng, Fangjie Zhang
Response to: ‘Can biomarkers differentiate psoriatic arthritis from osteoarthritis?’ by Tian et al
(4 July, 2019) Free
Vinod Chandran, Richard J Cook, Dafna D Gladman
2019 update of the EULAR recommendations for the management of SLE: don’t forget chloroquine (24 May, 2019) Free
Gabriel Figueroa-Parra, Carmen Magdalena Gamboa-Alonso, Ana Laura De-Leon-Ibarra, Dionicio Angel Galarza-Delgado
Chloroquine as alternative antimalarial in systemic lupus erythematosus. Response to ‘2019 update of the EULAR recommendations for the management of SLE: don’t forget chloroquine’ by Figueroa-Parra et al
(8 June, 2019) Free
Antonis Fanouriakis, George K Bertsias, Dimitrios T Boumpas
SLE-DAS: ready for routine use? (24 May, 2019) Free
Anoop Mathew, Kavadichanda G Chengappa, Sanket Shah, Vir Singh Negi
Response to: ‘SLE-DAS: ready for routine use’ by Mathew et al
(14 June, 2019) Free
Diogo Jesus, Ana Matos, Carla Henriques, Margherita Zen, Andrea Doria, Luís Sousa Inês
Correction: Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis
(14 August, 2020)
Correction: Metformin limits osteoarthritis development and progression through activation of AMPK signalling
(14 August, 2020) Free
Correction: Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction
(14 August, 2020)
Correction: Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase llb, randomised, double blind, placebo-controlled, dose-ranging study
(14 August, 2020)

Main menu

Table of contents

September 2020 - Volume 79 - 9

Editorial

Review

Viewpoint

Heroes and pillars of rheumatology

Epidemiology

Rheumatoid arthritis

Spondyloarthritis

Systemic sclerosis

Myositis

Vasculitis

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

September 2020 - Volume 79 - 9

Editorial

Review

Viewpoint

Heroes and pillars of rheumatology

Epidemiology

Rheumatoid arthritis

Spondyloarthritis

Systemic sclerosis

Myositis

Vasculitis

Letters

Electronic pages

Issue Information